Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Trenkwalder

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
American Journal of Hypertension|August 20, 2005
Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE)Ingmar Skoog, Hans Lithell, Lennart Hansson, et al.
Journal of Hypertension|April 26, 2003
The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trialHans Lithell, Lennart Hansson, Ingmar Skoog, et al.
Blood Pressure|April 13, 2005
The Study on COgnition and Prognosis in the Elderly (SCOPE) - major CV events and stroke in subgroups of patientsPeter Trenkwalder, Dag Elmfeldt, Albert Hofman, et al.
Deutsche Medizinische Wochenschrift (1946)|September 6, 2017
[Blood Pressure Measurement and Treatment Targets: Position Paper of the DHL® Task Force Scientific Statements and Guidelines]Bernhard K Krämer, Martin Hausberg, Bernd Sanner, et al.
Journal of the American College of Cardiology|September 15, 2004
Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE)Vasilios Papademetriou, Csaba Farsang, Dag Elmfeldt, et al.
Blood Pressure. Supplement|June 13, 2003
Valsartan/hydrochlorothiazide is effective in hypertensive patients inadequately controlled by valsartan monotherapyJean-Michel Mallion, Renzo Carretta, Peter Trenkwalder, et al.
Blood Pressure|July 20, 2002
Cognitive function and health-related quality of life in elderly patients with hypertension--baseline data from the study on cognition and prognosis in the elderly (SCOPE)Alessio Degl'Innocenti, Dag Elmfeldt, Lennart Hansson, et al.
Journal of Hypertension|June 14, 2008
The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension LeagueStephan Lüders, Joachim Schrader, Jürgen Berger, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
American Journal of Hypertension|August 20, 2005
Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE)Ingmar Skoog, Hans Lithell, Lennart Hansson, et al.
Journal of Hypertension|April 26, 2003
The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trialHans Lithell, Lennart Hansson, Ingmar Skoog, et al.
Blood Pressure|April 13, 2005
The Study on COgnition and Prognosis in the Elderly (SCOPE) - major CV events and stroke in subgroups of patientsPeter Trenkwalder, Dag Elmfeldt, Albert Hofman, et al.
Deutsche Medizinische Wochenschrift (1946)|September 6, 2017
[Blood Pressure Measurement and Treatment Targets: Position Paper of the DHL® Task Force Scientific Statements and Guidelines]Bernhard K Krämer, Martin Hausberg, Bernd Sanner, et al.
Journal of the American College of Cardiology|September 15, 2004
Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE)Vasilios Papademetriou, Csaba Farsang, Dag Elmfeldt, et al.
Blood Pressure. Supplement|June 13, 2003
Valsartan/hydrochlorothiazide is effective in hypertensive patients inadequately controlled by valsartan monotherapyJean-Michel Mallion, Renzo Carretta, Peter Trenkwalder, et al.
Blood Pressure|July 20, 2002
Cognitive function and health-related quality of life in elderly patients with hypertension--baseline data from the study on cognition and prognosis in the elderly (SCOPE)Alessio Degl'Innocenti, Dag Elmfeldt, Lennart Hansson, et al.
Journal of Hypertension|June 14, 2008
The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension LeagueStephan Lüders, Joachim Schrader, Jürgen Berger, et al.
Pageof 3